Soumit Roy
Stock Analyst at Jones Trading
(2.73)
# 2,078
Out of 4,981 analysts
43
Total ratings
29.03%
Success rate
4.36%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Soumit Roy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGON CG Oncology | Initiates: Buy | $50 | $33.16 | +50.78% | 1 | Sep 8, 2025 | |
| TARA Protara Therapeutics | Initiates: Buy | $21 | $3.20 | +556.25% | 1 | May 22, 2025 | |
| AVBP ArriVent BioPharma | Initiates: Buy | $40 | $18.99 | +110.64% | 1 | May 20, 2025 | |
| ELVN Enliven Therapeutics | Maintains: Buy | $36 → $27 | $19.94 | +35.41% | 2 | May 16, 2025 | |
| ACRV Acrivon Therapeutics | Downgrades: Hold | n/a | $1.55 | - | 2 | May 16, 2025 | |
| ONCY Oncolytics Biotech | Downgrades: Hold | n/a | $1.31 | - | 2 | May 16, 2025 | |
| MURA Mural Oncology | Downgrades: Hold | n/a | $2.08 | - | 2 | Mar 25, 2025 | |
| CRVO CervoMed | Upgrades: Buy | $15 | $9.19 | +63.22% | 3 | Mar 13, 2025 | |
| NUVB Nuvation Bio | Initiates: Buy | $10 | $3.35 | +198.51% | 1 | Mar 12, 2025 | |
| BEAM Beam Therapeutics | Upgrades: Buy | $34 | $21.55 | +57.77% | 2 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $36 | $2.09 | +1,622.49% | 4 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $2.44 | +1,211.48% | 1 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.21 | - | 1 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $11.66 | -22.81% | 1 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $10.86 | +56.54% | 1 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $13 | $2.71 | +379.70% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $4 | $0.88 | +353.51% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.16 | - | 2 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $5.27 | - | 1 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $26 | $6.62 | +292.75% | 2 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $25.12 | +178.66% | 1 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $10 | $47.67 | -79.02% | 2 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $6.83 | - | 2 | May 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $12.25 | +553.06% | 1 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.68 | - | 2 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $320 | $3.32 | +9,538.55% | 1 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $810 | $4.98 | +16,165.06% | 1 | Feb 24, 2021 |
CG Oncology
Sep 8, 2025
Initiates: Buy
Price Target: $50
Current: $33.16
Upside: +50.78%
Protara Therapeutics
May 22, 2025
Initiates: Buy
Price Target: $21
Current: $3.20
Upside: +556.25%
ArriVent BioPharma
May 20, 2025
Initiates: Buy
Price Target: $40
Current: $18.99
Upside: +110.64%
Enliven Therapeutics
May 16, 2025
Maintains: Buy
Price Target: $36 → $27
Current: $19.94
Upside: +35.41%
Acrivon Therapeutics
May 16, 2025
Downgrades: Hold
Price Target: n/a
Current: $1.55
Upside: -
Oncolytics Biotech
May 16, 2025
Downgrades: Hold
Price Target: n/a
Current: $1.31
Upside: -
Mural Oncology
Mar 25, 2025
Downgrades: Hold
Price Target: n/a
Current: $2.08
Upside: -
CervoMed
Mar 13, 2025
Upgrades: Buy
Price Target: $15
Current: $9.19
Upside: +63.22%
Nuvation Bio
Mar 12, 2025
Initiates: Buy
Price Target: $10
Current: $3.35
Upside: +198.51%
Beam Therapeutics
Mar 10, 2025
Upgrades: Buy
Price Target: $34
Current: $21.55
Upside: +57.77%
Feb 11, 2025
Upgrades: Buy
Price Target: $36
Current: $2.09
Upside: +1,622.49%
Jan 28, 2025
Initiates: Buy
Price Target: $32
Current: $2.44
Upside: +1,211.48%
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.21
Upside: -
Oct 31, 2024
Initiates: Buy
Price Target: $9
Current: $11.66
Upside: -22.81%
Oct 31, 2024
Initiates: Buy
Price Target: $17
Current: $10.86
Upside: +56.54%
Sep 17, 2024
Initiates: Buy
Price Target: $13
Current: $2.71
Upside: +379.70%
Sep 11, 2024
Maintains: Buy
Price Target: $6 → $4
Current: $0.88
Upside: +353.51%
Jul 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.16
Upside: -
May 15, 2024
Downgrades: Hold
Price Target: n/a
Current: $5.27
Upside: -
Apr 17, 2024
Maintains: Buy
Price Target: $22 → $26
Current: $6.62
Upside: +292.75%
Apr 16, 2024
Initiates: Buy
Price Target: $70
Current: $25.12
Upside: +178.66%
Apr 11, 2024
Upgrades: Buy
Price Target: $10
Current: $47.67
Upside: -79.02%
May 23, 2023
Downgrades: Hold
Price Target: n/a
Current: $6.83
Upside: -
Apr 19, 2023
Initiates: Buy
Price Target: $80
Current: $12.25
Upside: +553.06%
Nov 16, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.68
Upside: -
Nov 8, 2022
Initiates: Buy
Price Target: $320
Current: $3.32
Upside: +9,538.55%
Feb 24, 2021
Initiates: Buy
Price Target: $810
Current: $4.98
Upside: +16,165.06%